National Leprosy Eradication Progarmme

You might also like

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 10

NATIONAL LEPROSY

ERADICATION PROGARMME
CURRENT STATUS OF LEPROSY
 The prevalence of leprosy has been brought down
from 57.6 cases/10,000 population to 0.72/10,000 in
March 2009.
 32 states/UTs have achieved the status of leprosy
elimination except for Bihar, Chattisgarh, D & N
Haveli.
 Proportion of children among the new cases is 10.2%.
 Among new cases, 2.8% have visible deformity and
48% were MB cases.
HISTORICAL PRESPECTIVE
 1955 : National Leprosy control prog was launched.
( early case detection of cases and regular sustained
Dapsone monotherapy)
 1983 : National Leprosy Eradication programme
with MDT.
 1988 : Whole country was covered with MDT
Technical guidelines :
case detection
 Mainly voluntary reporting.
 Active case search is indicated in blocks where PR is more than
5/10,000.
 Case detection is mainly on clinical grounds.
 Disease activity status is indicated by
 Erythema and infiltration
 Tender nerves
 Extension or appearance of new skin lesions
 Extension of anaesthesia or paresis or occurrence of new
anaesthetic areas.
 Presence of acid fast bacilli in new skin lesions.
Technical guidelines :
case detection
 WHO CLASSIFICATION
Paucibacillary Multibacillary
PB MB
Skin lesions
≤ 5 lesions 6 and more
lesions
Nerve involvement
No /only one More than one
nerve trunk nerve trunk
involved involved
Technical guidelines :
Treatment Regimen
 Multibacillary (adult)
Duration : 12 months
Supervised once a month :
Rifampicin 600mg
Clofazimine 300mg
Dapsone 100mg PLUS
Unsupervised daily (self administered) :
Clofazimine 50mg
Dapsone 100mg
Technical guidelines :
Treatment Regimen
 Paucibacillary (adult)
Duration : 6 months
Supervised once a month :
Rifampicin 600mg
Dapsone 100mg PLUS
Unsupervised daily (self administered) :
Dapsone 100mg

MDT drugs are supplied in blister calendar packs each containing four
weeks treatment.
c/I for drugs : severe anaemia, liver and kidney disorders
Technical guidelines :
case holding
 Regular attendance of patients is ensured
through intensive health education, pre-clinic
motivation and default retrieval action
through contact by leprosy workers or by
mailing reminders.
Technical guidelines :
Surveillance
 It is done by clinical examination at the time
of completion of treatment and
subsequentaly annually for 2yrs in PB and
5yrs in MB cases.
Major initiatives

 Treatment completion rate


 Disability Prevention and Medical
Rehabilitation
 Intensive IEC
 Involvement of NGOs

You might also like